# Transfusion Effects in Myelodysplastic Patients: Limiting Exposure

> **NCT00202371** · PHASE4 · WITHDRAWN · sponsor: **Sanquin Research & Blood Bank Divisions**

## Conditions studied

- Myelodysplastic Syndromes

## Interventions

- **PROCEDURE:** Red Blood Cell transfusion

## Key facts

- **NCT ID:** NCT00202371
- **Lead sponsor:** Sanquin Research & Blood Bank Divisions
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2002-07
- **Primary completion:** —
- **Final completion:** 2005-07
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Too few inclusions
- **Last updated:** 2023-11-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00202371

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00202371, "Transfusion Effects in Myelodysplastic Patients: Limiting Exposure". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00202371. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*